What is PT 141?
PT-141, also known as Bremelanotide, is a synthetic peptide that primarily works as a treatment for sexual dysfunction. Unlike other treatments for erectile dysfunction (ED) or female sexual dysfunction, such as Viagra or Cialis, which affect the vascular system, PT-141 acts directly on the nervous system, specifically targeting the brain to enhance sexual arousal and desire.
Key Benefits of PT-141
-
Treatment for Erectile Dysfunction (ED):
- PT-141 is used to help men who suffer from erectile dysfunction by increasing sexual arousal and performance.
-
Treatment for Female Sexual Dysfunction:
- It has been approved by the FDA (in 2019) as a treatment for hypoactive sexual desire disorder (HSDD) in premenopausal women. It can help improve sexual desire and responsiveness by influencing brain pathways related to sexual arousal.
-
Works on the Central Nervous System:
- Unlike other ED medications that focus on increasing blood flow to the genital area, PT-141 stimulates receptors in the brain (specifically the melanocortin receptors), promoting sexual desire and arousal at a neurological level.
-
Fast-Acting:
- PT-141 can produce results relatively quickly, with effects sometimes appearing within 30 minutes to a few hours after administration.
How PT-141 Works
PT-141 is a melanocortin receptor agonist, meaning it binds to and activates melanocortin receptors in the brain, which are associated with sexual desire and arousal. By activating these receptors, PT-141 can increase libido and sexual interest in both men and women.
Administration
- PT-141 is typically administered via a subcutaneous injection (under the skin), though a nasal spray version has been developed and is becoming more common for convenience.
- Dosing and timing are important, as it should be taken at least 30 to 60 minutes before sexual activity.
Side Effects
- Common side effects include nausea, flushing, headache, and, in some cases, an increase in blood pressure.
- Some users also report temporary fatigue or injection site reactions.
FDA Approval and Use:
- PT-141 (Bremelanotide) was approved by the FDA for female sexual dysfunction (HSDD) in premenopausal women, but it is also used off-label by men for erectile dysfunction.
- It’s considered an alternative option for individuals who don’t respond well to traditional medications like Viagra, Cialis, or other PDE-5 inhibitors.
PT-141 is different from other sexual enhancement drugs because it works on the brain's pathways rather than the blood vessels, offering a novel approach to treating sexual desire disorders.
Supplied for Research Purposes Only
Check out our Independent Lab Analysis.
This information and product is provided for research purposes only. We do not provide any advice on the usage of these products as UK Law prevents this. Customers should check the legality of this product in their own country prior to purchase.
Also known as/branded as:
- Bremelanotide
- Vyleesi